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The cytotoxicity of resveratrol and of piceatannol, a structural analog of resveratrol, was examined in 
cultured cells. Using a MTT-based assay, which measures the conversion of 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl tetrazolium bromide (MTT) to a colored formazan product in living cells, resveratrol 
was found to inhibit the viability of transformed mouse macrophages, tumor-derived human T cells and 
human epidermoid carcinoma cells in a concentration-dependent manner, with the effect decreasing 
in the order: T cells (LC50 ∼27 µmol L
-1, 24 h; ∼9 µmol L-1; 48h) > macrophages (LC50 ∼29 µmol L
-1,
24 h; 39 µmol L-1, 48 h) > skin cells (LC50 ∼91 µmol L
-1, 24 h ; ∼66 µmol L-1, 48 h). Paradoxically, a 
high concentration of resveratrol (50 µmol L-1) inhibited the proliferation of all three cell types, and a low 
concentration (5 µmol L-1) stimulated the proliferation of macrophages. The viability of macrophages was 
also decreased by piceatannol in a concentration-dependent manner. The stimulation of macrophages 
with zymosan lowered the cytotoxicity of both resveratrol and piceatannol. Scanning electron microscopy 
of cells treated with resveratrol revealed changes in cellular morphology that were consistent with toxicity. 
In macrophages and skin cells, resveratrol (50 µmol L-1) induced a time-dependent increase in reduced 
glutathione levels but did not alter the background levels of thiobarbituric acid-reactive substances. Taken 
together, the present data indicate that resveratrol is toxic to cultured macrophages, T cells and skin 
cells at concentrations ≥25 µmol L-1, and that the cytotoxicity occurs via a mechanism that does not 
involve oxidative stress. Furthermore, the degree of toxicity of both resveratrol and piceatannol towards 
macrophages depends on the activation status of these cells, with zymosan-activated cells appearing 
more resistant than nonstimulated cells.
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Resveratrol is an antioxidant compound naturally 
found in peanuts, pistachio nuts, red grape seeds and 
skins, red wine, and other plant-derived food products 
(1-5). From a chemical standpoint, the structure of this 
polyphenol (Figure 1) bears a close similarity to that of 
the synthetic estrogen diethylstilbestrol (6), a feature 
that may account for its reported estrogenic activity 
(7, 8). In plants, the synthesis of resveratrol is under 
the control of stilbene synthase, an enzyme that can 
undergo up-regulation in response to environmental 
stressors, such as exposure to ultraviolet light or 
infection (9, 10).
Numerous in vitro and in vivo studies have 
determined resveratrol to possess both cytoprotective 
and cytotoxic properties. Thus, in addition to 
functioning as an antioxidant and demonstrating 
cardioprotective, chemopreventive, and neuronal-
sparing effects (11-14), this compound is also 
reported to be tumoricidal, hemolytic, and toxic to 
the genitourinary tract (11, 15). The mechanism by 
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which resveratrol can act both as a cytoprotectant 
and as cytotoxicant may stem from the wide range 
of biological actions that it can exert in mammalian 
cells, including the regulation of cell proliferation, 
the induction of apoptosis, the promotion of cell 
differentiation, the inhibition of pro-inflammatory 
mediator production, and the suppression of reactive 
oxygen and nitrogen species formation (14, 16-18).
With respect to its effects on the immune system, 
resveratrol exhibits antiproliferative activity and 
appears to be a potent inducer of T cell apoptosis (19-
23). Though the anti-proliferative effects of resveratrol 
on macrophages have not been fully studied and 
defined, its potent anti-inflammatory properties toward 
cells participating in nonspecific immunity has been 
observed. To this end, resveratrol is a potent inhibitor 
of reactive oxygen species produced by zymosan-
stimulated macrophages, monocytes, and neutrophils 
(24). Resveratrol and its analogs have also been 
found to inhibit the production of proinflammatory 
mediators such as prostaglandins and nitric oxide 
from stimulated macrophages exposed to endotoxin 
(25). Whereas these two studies demonstrate how 
macrophages stimulated with immunogens such 
as zymosan or endotoxins respond to resveratrol, 
the response of nonstimulated macrophages to 
a challenge with this polyphenol remains poorly 
defined. Similarly, the cytotoxic potential of resveratrol 
towards skin cells is at present unclear. However, while 
evidence exists to suggest an antiproliferative activity 
of this compound on certain types of skin cells in vitro
(26-28), data generated from in vivo studies have not 
been as conclusive (29).
Therefore, the present study was undertaken 
with three specific aims: (a) to evaluate the cytotoxic 
properties of resveratrol in vitro by using RAW264.7 
macrophages, CEM T cells, and A-431 skin cells; 
(b) to determine if resveratrol has any effect on the 
intracellular antioxidant status; and (c) to compare the 
cytotoxicity of resveratrol with that of its metabolite 
piceatannol, a hydroxylated analog of resveratrol, in 






l]benzene-1,2-diol), zymosan (from Saccharomyces 
cerevisiae), and all other chemicals, unless otherwise 
indicated, were obtained from Sigma Chemical 
Company (St Louis, MO). The declared purity of both 
resveratrol and piceatannol was >99 %.
Cells and cell culturing conditions
RAW264.7 mouse macrophages and A-431 
human epidermoid carcinoma cells were obtained 
from the American Type Culture Collection (Manassas, 
VA). The former cells were established from a tumor 
induced by Abelson murine leukemia virus (30), and 
the latter ones were skin cells established from a solid 
tumor in an elderly female (31). CEM cells are human 
T lymphoblasts originally isolated from the peripheral 
blood of a child with acute lymphocytic leukemia 
(32) and were kindly provided by Dr. Jason Chen (St. 
John’s University, Jamaica, NY). In all experiments, 
cells were grown to 90 % confluence in Dulbecco’s 
Modified Eagle’s Medium (DMEM) containing 
glutamine, 4.5 g L-1 glucose, 0.1 mg mL-1 gentamicin 
(Invitrogen), and 10 % heat-inactivated fetal bovine 
serum (complete DMEM) on 24-well plates.
Cell viability studies
Macrophages and A-431 cells. All media was 
removed from the wells and replaced with 0.5 mL 
of serum-free and phenol red-free growth medium 
containing increasing concentrations of resveratrol 
(0 µmol L-1 to 50 µmol L-1). In studies evaluating the 
effect of immunostimulation of macrophages with 
zymosan, the medium was replaced with serum- 
Figure 1 Chemical structures of resveratrol (5-[2-(4-hydroxyphenyl)
vinyl]benzene-1,3-diol), and piceatannol (4-[2-(3,5-dihydro-
xyphenyl)vinyl]benzene-1,2-diol)
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and phenol red-free growth medium containing 
increasing concentrations of resveratrol or piceatannol 
(0 µmol L-1 to 50 µmol L-1) plus zymosan (0 µmol L-1
to 30 µg mL-1). All cells were cultured for either 24 h 
or 48 h, after which the MTT viability assay was 
performed as described by Mosmann (33). In separate 
experiments, macrophages were similarly treated with 
piceatannol (0 µmol L-1 to 50 µmol L-1).
T cells. Cells were grown to 90 % confluence in 
complete DMEM in cell culture plates, after which they 
were divided into four equal portions, centrifuged, and 
re-fed with serum-free and phenol red-free growth 
medium containing increasing concentrations of 
resveratrol (0 µmol L-1to 50 µmol L-1). Cells were then 
cultured for 24 h or 48 h, after which the MTT assay 
was performed.
Cell proliferation studies
Macrophages, T cells, and human epidermoid 
carcinoma cells were inoculated into 6- well plates 
(1x104 cells/well), and cultured in complete DMEM 
in the absence or presence of resveratrol (0 µmol L-1
to 50 µmol L-1). Cells were harvested at specified 
intervals, and the number of cells per well was 
determined with the aid of a hemocytometer. The 
cells were washed twice with phosphate buffered saline 
(PBS) prior to harvesting, and only those cells able to 
exclude trypan blue were counted.
Scanning electron microscopy
Nonadherent T cells were grown in culture solution 
and adherent skin cells were grown on cover slips. 
Both cell types were seeded in 6-well plates and 
exposed to increasing concentrations of resveratrol 
(0 µmol L-1 to 100 µmol L-1) for 24 h or 48 h. Prior 
to fixation, T cells were isolated by filtration onto 
filter paper with the aid of suction. All samples were 
washed with PBS, and fixed in 1.5 % glutaraldehyde 
in phosphate buffer (pH 7.4) for 1 h at 0 °C to 4 °C. 
Dehydration was accomplished through a series of 
water to acetone steps. Cells were critically point 
dried (CPD) in a Polaron E 3000 using bone dry 
carbon dioxide as a transition fluid, and sputter-coated 
with 15 nm  of platinum for 90 s using a Polaron E 
5100 series II coater set at 2.5 kV. The specimens 
were viewed on a Hitachi S-530 scanning electron 
microscope at 25 kV with a eucentric stage.
Glutathione assay
The intracellular levels of reduced glutathione 
(GSH) in both macrophages and epidermoid 
carcinoma cells were measured by an adaptation 
of the method described by Tietze (34). Briefly, cells 
were first incubated in the presence (50 µmol L-1) or 
absence of resveratrol for either 24 h or 48 h, then 
washed twice with PBS, scraped, and collected into 
microfuge tubes and followed by a brief centrifugation. 
After discarding the supernatant, the cell pellet was 
resuspended in 100 µL of PBS, freeze/thawed three 
times, mixed with 100 µL of 5 % metaphosphoric acid, 
and centrifuged at 14000 rpm for 5 min. A 100 µL 
of volume of supernatant was withdrawn, transferred 
to a new microfuge tube, and mixed with a reagent 
solution containing triethanolamine, EDTA, PBS, and 
5,5’-dithiobis (2-nitrobenzoic acid). The absorbance 
of the solution was read on a spectrophotometer at 
405 nm , and used to calculate the GSH content by 
comparison to a GSH standard curve prepared from 
graded dilutions of a GSH solution (1 mmol L-1 in 
water).
Lipid peroxidation
Evidence of lipid peroxidation in both macrophages 
and epidermoid carcinoma cells was obtained by 
measuring the levels of malondialdehyde (MDA) 
present as thiobarbituric acid reactive substances 
(TBARS) according to Fraga (35). Briefly, cells were 
treated with increasing concentrations of resveratrol 
(0 µmol L-1 to 50 µmol L-1), incubated for 48 hr, 
collected into microfuge tubes and then centrifuged 
at 4000 rpm for 10 min. Separate groups of cells 
were also incubated for 48 hr in the presence of 
varying concentrations of the nitrogen mustard 
mechlorethamine (0 µmol L-1to 50 µmol L-1), a known 
inducer of TBARS formation, to serve as a positive 
control. From each sample, 400 µL of supernatant 
was removed, transferred to a test tube, mixed with 
800 µL of TBARS reagent (15 g of trichloroacetic 
acid, 0.375 g of thiobarbituric acid, 4.16 mL of 
6 mol L-1 HCl in sufficient water to make 100 mL), 
and incubated at 95 °C for 1 h. After cooling the tube 
under running water, the absorbance of the solution 
was read at 532 nm. The concentration of TBARS 
was calculated by comparison to a MDA standard 
curve prepared from graded dilutions of 1,1,3,3-
tetraethoxypropane (10 ng mL-1 in water) and treated 
as the samples.
Statistical analysis of data
Unless otherwise indicated, all experiments were 
carried out in triplicate, and their results are reported 
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as the mean ± standard error of the mean from at 
least three representative experiments. Statistical 
comparisons were made using GraphPad Prism 
4.0® software (GraphPad Software, Inc., San Diego, 
CA) by Student’s t-test, followed by one-way ANOVA 
and Newman-Keuls post hoc test. Differences were 
considered to be significant at p<0.05.
RESULTS AND DISCUSSION
The effect of resveratrol on cell viability was 
ascertained by a standard MTT assay after culturing 
A-431 skin cells, RAW264.7 macrophages, and 
CEM T cells for 24 h and 48 h in serum-free DMEM 
containing 0 µmol L-1 to 75 µmol L-1 of resveratrol. 
Resveratrol reduced the viability of all three cell types in 
a concentration-dependent manner (Table 1). Among 
these three cell types, skin cells were the most resistant 
(LC50 ∼91 µmol L
-1 at 24 h and ∼66 µmol L-1 after 
48 h), T cells the least resistant (LC50 ∼27 µmol L
-1 at 
24 h and ∼9 µmol L-1 after 48 h), and macrophages 
exhibited an intermediate sensitivity (LC50 ∼29 µmol L
-1
at 24 h and ∼39 µmol L-1 after 48 h) to resveratrol. 
Finding that the LC50 value for macrophages 
incubated with resveratrol for 48 h to be higher than 
that of cells treated for only 24 h was unexpected and 
deserving of a future explanation. It is possible that 
the macrophages mobilize defense mechanisms that 
will protect them from the treatment agent and which 
only become fully active after 24 h. Alternately, these 
cells might metabolize the compound over time to a 
form that is less toxic. It is likely that the decreased 
viability of all three cell types in the presence of 
resveratrol is occurring, at least in part, through a 
mechanism ending in apoptosis. This assumption is 
based on reports from other laboratories describing 
the occurrence of DNA fragmentation in cells exposed 
to this natural polyphenol in vitro (36-38).
Finding that relatively higher concentrations of 
resveratrol are required to kill skin cells than either 
macrophages or T cells is taken as a suggestion of a 
higher innate resistance to resveratrol by cells derived 
from solid tumors than blood-derived tumor cells and, 
at the same time, may explain why resveratrol failed to 
prevent the spread of melanoma cells, another type 
of tumor-derived skin cell, in a mouse model (29). 
Differences in cell sensitivity to resveratrol may also 
be related to the presence of p53, a protein known 
to play a role in a cell response to DNA damage by 
xenobiotics, including resveratrol (39-41). In particular, 
human epidermoid cells have been found to express a 
mutated form of p53 that codes for a missense variant 
(Arg to His at codon 273, R273H) (42,43). Expression 
of the p53-R273H variant in skin cells has been found 
to increase cellular resistance towards other toxic 
compounds such as methotrexate and doxorubicin 
and may, in part, contribute to the greater resistance 
of skin cells to resveratrol than either macrophages 
or T cells (43).
Scanning electron microscopy (SEM) was used 
to determine if cytotoxicity by resveratrol was also 
accompanied by changes in cell morphology. As shown 
in Figure 2, left panel, untreated T cells demonstrated 
a normal morphology and a smooth surface. 
However, the treatment of these cells with resveratrol 
(50 µmol L-1; 24 h) led to the morphological changes 
seen in Figure 2, center panel. Deterioration of the cell 
membrane is evident, resulting in a rough appearance 
of the cells. Doubling the concentration of resveratrol 
(100 µmol L-1; 24 h), caused the T cells to become 
crumpled and to acquire a deflated appearance 
(Figure 2, right panel), changes which paralleled 
their decrease in viability. The effects of resveratrol 
on skin cells differed somewhat from those observed 
with T cells. For example, at a lower concentration of 
resveratrol (5 µmol L-1; 48 h) the morphology of these 
cells (Figure 3, center panel) was no different from 
that of untreated cells (Figure 3, left panel). However, 
a high concentration of resveratrol (100 µmol L-1;
48 h) resulted in obvious morphological alterations 
(Figure 3, right panel). Blebbing of the membrane 
Table 1 Effect of resveratrol on cell viability
Cell type LC50 value (µmol L
-1) a,b
24 h 48 h
 RAW264.7 macrophages 29.1±2.53 (N=13) 39.1±2.81 (N=17)
 CEM T cells 27.3±6.71 (N=3) 8.88±1.04 (N=4)**
 A-431 epidermoid cells 91.0±6.66 (N=3) 66.0±8.72 (N=3)**
aLC50 values represent the mean ± the standard error of the mean
bSignificantly different from cells treated with resveratrol for 24 h by Student’s t-test and ANOVA at **p<0.01
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was observed and was accompanied by alterations of 
cellular projections consistent with toxicity and lack of 
cell viability. The possibility that cell blebbing is due 
to the disruptive action of resveratrol on tubulin is 
suggested by a recent study in which the resveratrol 
analog 3,4’,5-trimethoxystilbene was shown to display 
a potent anti-mitotic action in Caco-2 cells through 
inhibition of tubulin polymerization (44, 45).
To study the effect of resveratrol on the proliferation 
of skin cells, macrophages, and T cells, these cells 
were separately seeded at a low density on culture 
dishes, and grown in serum-containing DMEM plus 
0 µmol L-1 to 75 µmol L-1 of resveratrol. Periodically, 
the viability of the growing cells was checked using 
the trypan blue exclusion method. The effects of 
resveratrol varied according to the cell type. Thus, it was 
unexpectedly found to exert a dual effect on the growth 
of macrophages (Figure 4), with a low concentration 
(5 µmol L-1) stimulating cell proliferation and higher 
concentrations (25 µmol L-1 and 50 µmol L-1) inhibiting 
it. In contrast, resveratrol was found to inhibit the growth 
of skin cells (25 µmol L-1 and 50 µmol L-1) and T cells
(50 µmol L-1) with no significant growth-stimulatory 
effects at lower concentrations. The present findings 
for macrophages, although somewhat surprising, are 
not untenable. Thus, whereas a number of studies 
looking at the influence of resveratrol on cell growth 
find this compound to only exert an antiproliferative 
effect (20-24), there is at least one report in support 
of a stimulatory effect in osteoblasts in vitro (46). 
Furthermore, the dual effect of resveratrol on the 
growth of macrophages is comparable to the effect 
described for quercetin (47, 48), a plant flavonoid 
which shares a number of other bioactivities with 
resveratrol.
To determine if resveratrol could influence the 
intracellular antioxidant status, the cellular levels of 
GSH were measured in macrophages and skin cells 
Figure  2 Effect of resveratrol on T cell morphology (24 h treatment). Left panel, vehicle control; center panel, cells treated with 50 µmol L-1
resveratrol; right panel, cells treated with 100 µmol L-1 of resveratrol. In these panels, the cells are observed as round structures and 
the grayish-fibrous material on which the cells are resting is the filter paper onto which the nonadherent T cells were suction-filtered 
during preparation of the samples for viewing. It is apparent that treating the cells with 50 µmol L-1 and 100 µmol L-1 of resveratrol led 
to significant membrane damage
Figure 3  Effect of resveratrol on skin cell morphology (48 h treatment). Left panel, vehicle control; center panel, cells treated with 5 µmol L-1 of 
resveratrol; right panel, cells treated with 100 µmol L-1 of resveratrol. Cells treated with 100 µmol L-1 of resveratrol exhibited significant 
membrane blebbing compared to controls
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in the absence and presence of this compound. 
Regardless of the cell type, an exposure to resveratrol 
(50 µmol L-1) was found to significantly elevate the 
intracellular GSH above the levels of untreated cells 
(Table 2). In macrophages, elevations in GSH levels 
amounted to about 2-fold and 7.7-fold after 24 h and 
48 h, respectively. In skin cells, on the other hand, the 
GSH level was about 3.7-fold higher after 24 h than 
that of untreated cells. Furthermore, treatment of 
T cells with resveratrol has been previously found in 
this laboratory to increase the cellular GSH content 
(data not shown). A similar trend of results has been 
observed in resveratrol-treated endothelial (49) and 
cardiac (50) cells. In turn, the stimulatory effect for 
resveratrol could be centered on two key enzymes 
for GSH synthesis, glutathione synthetase (GS) and 
g-glutamyl-cysteinyl ligase (GCL). Expression of these 
enzymes is controlled by the antioxidant/electrophilic 
response element (ARE/EpRE) which is activated by 
bZIP transcription factors such as Nrf2 (51). Hence, 
it is conceivable that resveratrol could be increasing 
intracellular pools of GSH in macrophages, skin 
cells, and T cells by activating Nrf2. This view is 
supported by a recent study which found resveratrol 
to activate Nrf2-dependent transcription in vitro (52). 
Although definitive proof of this effect will necessitate 
a future investigation, the results derived from our 
experiments clearly rule out a mechanism involving 
the reduction of cellular antioxidants as being part of 
the antiproliferative effect of resveratrol.
The potential for resveratrol to foster lipid 
peroxidation and, in this manner, to contribute to 
cytotoxicity, was examined in the macrophages and 
skin cells. Although the majority of published studies 
find resveratrol to have potent antioxidant properties, 
there are also reports indicating that this polyphenol 
Figure 4  Effect of resveratrol on cell proliferation. Left panel, transformed mouse macrophages (RAW264.7); center panel, transformed human
T cells (CEM); right panel, tumor-derived skin cells (A-431). Values are given as the mean ± the standard error of the mean for three 
samples selected from representative experiments. For the entire duration of the experiment, cells were incubated in the absence (0.1 % 
DMSO, filled circles), or presence of 5 µmol L-1 (open circles), 25 µmol L-1 (filled triangles) or 50 µmol L-1 (open triangles) resveratrol.
Table 2 Effect of resveratrol on cellular levels of reduced glutathione (GSH)
Cell type GSH (nmol x 106 cells)a
24 hb 48 hc
RAW264.7 macrophages
Control 9.27±1.28 9.03±0.83
Resveratrol (50 µmol L-1) 19.40±4.05* 69.1±27.3††
A-431 epidermoid cells
Control 873.9±116.3 NDd
Resveratrol (50 µmol L-1) 3193.8±212.6* NDd
aValues represent the mean±the standard error of the mean from 3 independent experiments
bSignificantly different from control cells at 24 h by Student’s t-test at *p<0.05
cSignificantly different from control cells at 48 h by Student’s t-test at ††p<0.01
dND: not determined
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can act as a prooxidant (53-55). In the present study, 
a treatment with resveratrol (0 µmol L-1 to 50 µmol L-1)
did not result in levels of TBARS that were significantly 
different from those in untreated cells (Table 3). 
Although decreases in viability occurred at these 
concentrations of resveratrol in macrophages and skin 
cells (see Table 1, 48 h), and microscopic alterations 
consistent with toxicity were observed in skin cells at 
a higher (100 µmol L-1) resveratrol concentration (see 
Figure 3), the decrease in viability was not dependent 
on the accumulation of lipid peroxidation products.
To determine whether resveratrol can influence 
nonstimulated macrophages in the same manner 
and extent as stimulated cells, RAW264.7 cells were 
treated with resveratrol or the related compound 
piceatannol, (0 µmol L-1 to 50 µmol L-1; 48 h), in the 
presence or absence of zymosan. Zymosan, from the 
cell wall of Saccharomyces cerevisiae, is composed 
of polysaccharides that are complexed with proteins 
and lipids (56), and acts as a potent stimulator of the 
Toll-like receptors TLR2 and TLR6 (57). Activation 
of these receptors by zymosan in macrophages 
triggers several signaling pathways, culminating in 
the release of cytotoxic products such as reactive 
oxygen and nitrogen-containing species, including 
the very reactive chemical species nitric oxide (NO•),
superoxide anion (O2•
-), and peroxynitrite (ONOO-)
(58-60). In addition, zymosan can bind to and activate 
other receptors on macrophages that promote the 
phagocytosis of foreign particles (61, 62). On these 
bases, it was reasoned that the cytotoxic properties 
of resveratrol on macrophages would be exacerbated 
following cell stimulation with zymosan. Unexpectedly, 
however, macrophages stimulated with zymosan were 
found to be significantly more resistant to the toxicity 
of resveratrol than nonstimulated ones (Table 4). A 
similar trend was observed for zymosan-stimulated 
macrophages treated with piceatannol (Table 4). 
Although an explanation accounting for these results 
is not apparent at the present time, future work 
should explore the role of TLR2 and TLR6. At the 
concentrations used here to activate macrophages 
(20 µg mL-1 to 30 µg mL-1), zymosan was previously 
found in this laboratory to stimulate the release of 
NO• and O2•
- from these cells to a significant extent 
and in a time-dependent manner (data not shown). 
Under this circumstance, and in light of two recent 
studies demonstrating the nitration of resveratrol 
and piceatannol under acidic conditions (63,64), 
we hypothesize that the reason why both of these 
structurally-related compounds are found to be less 
toxic in stimulated than in unstimulated macrophages 
may be the consequence of nitration by peroxynitrite 
which forms when NO• and O2•
- are released from 
activated cells. Nitration of resveratrol and piceatannol 
by peroxynitrite would significantly alter the trans-
stereochemistry of these agents (63,64) and could 
also potentially change their respective hydrophobic 
Table 3 TBARS production in RAW264.7 macrophages and A-431 skin cells
Cell type TBARS (nmol x 106 cells)a,b,c,d
RAW264.7 macrophages
Control 0.0013±0.0002
Resveratrol (25 µmol L-1) 0.0014±0.0002
Resveratrol (50 µmol L-1) 0.0013±0.0002
Mechlorethamine (25 µmol L-1) 0.0049±0.0005††
Mechlorethamine (50 µmol L-1) 0.0667±0.0148††
A-431 epidermoid cells
Control 0.0003±0.0002
Resveratrol (25 µmol L-1) 0.0003±0.0001
Resveratrol (50 µmol L-1) 0.0002±0.0001
Mechlorethamine (25 µmol L-1) 0.0094±0.0010††
Mechlorethamine (50  µmol L-1) 0.0144±0.0027††
aValues represent the mean±the standard error of the mean from 3 independent experiments
b Cells were cultured for 48 h in the absence or presence of each compound
cMechlorethamine was used as a positive control for lipid peroxidation (65)
dSignificantly different from control cells by Student’s t-test at ††p<0.01
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properties, thus, decreasing their ability to accumulate 
within the cells and bring about toxicity. A future study 
examining the response of macrophages to nitrated 
and non-nitrated forms of resveratrol will help to settle 
this issue.
CONCLUSIONS
The effect of resveratrol on cell growth, studied with 
macrophages, T cells and skin cells, varied according 
to the cell type and the concentration of compound 
added. In macrophages, a low concentration of 
this compound (5 µmol L-1) stimulated and a high 
concentration (50  µmol L-1) inhibited cell proliferation. 
At the higher concentration it also inhibited the growth 
of T cells and skin cells. However, growth-stimulatory 
effects were not observed in skin cells and T cells 
treated with the lower concentration of resveratrol.
The MTT viability assay found resveratrol to 
be cytotoxic to all three cell types when present in 
concentrations≥25 µmol L-1 at 24 h and ≥9 µmol L-1
at 48 h.
Scanning electron microscopy revealed resveratrol 
to alter the cell morphology at concentrations 
≥50 µmol L-1.
Cytotoxicity by resveratrol was accompanied by an 
increase in the intracellular levels of GSH, but not by 
alterations of the base line levels of TBARS.
Piceatannol, the hydroxylated metabolite of 
resveratrol, was cytotoxic to macrophages in the MTT 
viability test. However, this effect was attenuated to a 
significant extent by a cotreatment with zymosan.
Resveratrol was toxic to macrophages, T cells and 
skin cells. In the case of macrophages, the degree of 
toxicity appears to be related to the activation status of 
the cells since zymosan-activated macrophages were 
more resistant than nonstimulated cells.
The cytotoxicity that resveratrol manifested toward 
all cells studied appears not to involve oxidative stress 
since it led neither to glutathione depletion nor to the 
accumulation of TBARS.
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Sa`etak
EVALUACIJA CITOTOKSI^NOSTI RESVERATROLA I PICEATANOLA U MAKROFAZIMA, T-STANICAMA 
I STANICAMA KO@E
Citotoksi~nost resveratrola i piceatanola, strukturnog analoga resveratrola, ispitivana je u uzgojenim 
stanicama. Primjenom MTT-testa koji mjeri pretvorbu 3-[4,5-dimetiltiazol-2-il]2,5-difenil-tetrazolijeva 
bromida (MTT) u obojeni formazan produkt u ̀ ivim stanicama, na|eno je da resveratrol inhibira pre`ivljavanje 
transformiranih makrofaga mi{a, ljudskih tumorskih T-stanica i humanih stanica epidermoidnog karcinoma 
u ovisnosti o koncentraciji, a u~inak opada redom: T-stanice (LC50 ∼27 µmol L
-1, 24 h; ∼9 µmol L-1;
48 h) > makrofazi (LC50 ∼29 µmol L
-1, 24 h; 39 µmol L-1, 48 h) >stanice ko`e (LC50 ∼91 µmol L
-1, 24 h; 
∼66 µmol L-1, 48 h). Paradoksalno, pri visokoj koncentraciji resveratrola (50 µmol L-1) inhibirana je 
proliferacija svih triju tipova stanica, a pri niskim koncentracijma (5 µmol L-1) stimulirana je proliferacija 
makrofaga. Pre`ivljavanje makrofaga bilo je tako|er smanjeno primjenom piceatanola ovisno o 
koncentraciji. Stimulacija makrofaga zimosanom smanjila je citotoksi~nost i resveratrola i piceatanola. 
Skeniraju}a elektronska mikroskopija stanica tretiranih resveratrolom pokazala je promjene u morfologiji 
stanica, {to je bilo u skladu s toksi~nosti. U makrofazima i stanicama ko`e resveratrol (50 µmol L-1)
inducirao je porast smanjenja razina glutationa ovisan o vremenu, ali nije mijenjao osnovne razine reaktivnih 
spojeva tiobarbiturne kiseline. Gledaju}i skupno, prikazani rezultati indiciraju da je resveratrol toksi~an za 
uzgojene makrofage, T-stanice i stanice ko`e pri koncentracijama ≥25 µmol L-1 i da se citotoksi~nost zbiva 
mehanizmom koji ne uklju~uje oksidativni stres. Nadalje, stupanj toksi~nosti resveratrola i piceatanola 
prema makrofagima ovisi o aktivacijskom statusu tih stanica, pri ~emu su stanice aktivirane zimosanom 
rezistentnije od nestimuliranih stanica.
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